AutoImmune Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for AutoImmune Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

AutoImmune Inc.. The Company's principal activities are developing and marketing pharmaceutical products for the treatment of autoimmune and other cell-mediated inflammatory diseases. The products are based on the principles of mucosal tolerance. Mucosal tolerance utilizes the natural immune system mechanisms associated with the gut, nasal passages, lungs and other mucosally lined tissues. The Company presently focused on products for three diseases: rheumatoid arthritis, multiple sclerosis and Type 1 diabetes. It operates in the United States of America. The Company is in the development stage.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report